Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer After a Radical Treatment”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Post-approval studies (Phase 4)Study completedNCT01753297
What this trial is testing

Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.

Who this might be right for
Prostate Cancer
Ipsen 226
Large-scale testing (Phase 3)Looking for participantsNCT04242017
What this trial is testing

Long-term Better Than Short-term ADT With Salvage RT

Who this might be right for
Prostate Cancer
Universitaire Ziekenhuizen KU Leuven 394
Testing effectiveness (Phase 2)WithdrawnNCT01561482
What this trial is testing

Study of Metformin With Simvastatin for Men With Prostate Carcinoma

Who this might be right for
Prostate Carcinoma
Nicholas Mitsiades
Testing effectiveness (Phase 2)Looking for participantsNCT06305832
What this trial is testing

Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

Who this might be right for
Prostate CancerBiochemical Recurrence
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 102
Testing effectiveness (Phase 2)Study completedNCT00003323
What this trial is testing

Hormone Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate CancerSexual Dysfunction and Infertility
Alliance for Clinical Trials in Oncology 101
Not applicableNot Yet RecruitingNCT06435702
What this trial is testing

Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study

Who this might be right for
Prostate Cancer
Peking University Third Hospital 108
Testing effectiveness (Phase 2)Looking for participantsNCT05946824
What this trial is testing

This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.

Who this might be right for
Recurrent Prostate Cancer After Surgery
University of Rochester 80
Not applicableLooking for participantsNCT06657131
What this trial is testing

Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer After a Radical TreatmentBiochemical Recurrence of Malignant Neoplasm of ProstateBiochemical Persistence of Prostate Cancer
Heinrich-Heine University, Duesseldorf 250
Testing effectiveness (Phase 2)Study completedNCT03311555
What this trial is testing

A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)

Who this might be right for
Prostate Cancer
Andrew J. Armstrong, MD 39
Not applicableStudy completedNCT05200039
What this trial is testing

Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part IIB

Who this might be right for
Prostate CancerSurvivorshipPhysical Function+2 more
Sykehuset Innlandet HF 109
Testing effectiveness (Phase 2)Looking for participantsNCT06449781
What this trial is testing

177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Maria Sklodowska-Curie National Research Institute of Oncology 200
Testing effectiveness (Phase 2)Study completedNCT00528866
What this trial is testing

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 80
Testing effectiveness (Phase 2)Study completedNCT03570827
What this trial is testing

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+3 more
Mayo Clinic 53
Testing effectiveness (Phase 2)WithdrawnNCT00003858
What this trial is testing

Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology
Early research (Phase 1)Ended earlyNCT00480623
What this trial is testing

A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence

Who this might be right for
Prostate Cancer
Agennix
Testing effectiveness (Phase 2)Study completedNCT02543255
What this trial is testing

Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)

Who this might be right for
Prostate Cancer
University Health Network, Toronto 76
Early research (Phase 1)Study completedNCT04701021
What this trial is testing

TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy

Who this might be right for
Prostate Cancer
Ultimovacs ASA 12
Large-scale testing (Phase 3)Study completedNCT00779402
What this trial is testing

PROvenge Treatment and Early Cancer Treatment

Who this might be right for
Prostate Cancer
Dendreon 176
Not applicableActive Not RecruitingNCT04067570
What this trial is testing

Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients With Localized Prostate Cancer

Who this might be right for
SBRTRadical Prostatectomy
Sunnybrook Health Sciences Centre 30
Testing effectiveness (Phase 2)UnknownNCT03899077
What this trial is testing

Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP

Who this might be right for
Cancer of Prostate
Cancer Research Antwerp 202
Load More Results